Results 271 to 280 of about 168,320 (317)
Some of the next articles are maybe not open access.
HPV Type Replacement After HPV Vaccination
Human papillomavirus (HPV) vaccination effectively reduces the risk of HPV-attributable cancers, including cervical, vulvar, vaginal, anal, oropharyngeal, and other head and neck cancers. Concerns for a lower-than-expected vaccine impact, as defined as an increase in the prevalence of precancer by nonvaccine types, compared to that anticipated based onElizabeth M, Anderson +2 more
openaire +2 more sources
Clinical Obstetrics & Gynecology, 2012
Human papilloma virus (HPV) is the most common sexually transmitted disease in the world. Almost 80% of the world's population is exposed by the age of 50. HPV can cause oropharyngeal, genital, and anal cancers. It also causes genital warts. There is no cure for HPV but vaccines are available to prevent infection by the most common HPV viruses ...
openaire +2 more sources
Human papilloma virus (HPV) is the most common sexually transmitted disease in the world. Almost 80% of the world's population is exposed by the age of 50. HPV can cause oropharyngeal, genital, and anal cancers. It also causes genital warts. There is no cure for HPV but vaccines are available to prevent infection by the most common HPV viruses ...
openaire +2 more sources
Characteristics of human papillomavirus (HPV), HPV-infection and anti-HPV vaccines
2007Ljudski papilomavirusi (engl. human papilloma virus, HPV) svrstani su u obitelj Papovaviridae, skupinu malih, neovijenih DNK virusa oblika ikozaedra. Naziv im je izveden od latinske riječi papilla (bradavica) i grčke riječi oma (tumor). Kapsida promjera 55-60 nm sastavljena im je od 72 podjedinice – kapsomere, a veliki protein kapside (L1) tvori ...
openaire
Immunology of HPV infection and HPV‐associated tumors
International Journal of Dermatology, 1998S, Majewski, S, Jablonska
openaire +2 more sources
HPV knowledge among HPV+ women.
American journal of health behavior, 2009To assess knowledge and information seeking among women recently receiving an HPV+ diagnosis.A 2-phase mixed methods design was used. In both phase I (qualitative) and phase II (quantitative), women with scheduled gynecological exams and Pap smears at clinic sites were approached to participate.Women expressed confusion about HPV, and most could not ...
Ellen M, Daley +8 more
openaire +1 more source